| Period Ending | Mar 31, 2010 | Mar 31, 2009 | Mar 31, 2008 | Mar 31, 2007 |
|---|
|
Total Revenue
|
30,153,000
|
33,156,000
|
42,801,000
|
33,881,000
| | Cost of Revenue | 16,765,000 | 10,542,000 | 16,890,000 | 13,140,000 | | |
Gross Profit
|
13,387,000
|
22,615,000
|
25,912,000
|
20,742,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 18,909,000 | 13,109,000 | 19,253,000 | 14,651,000 | | | |
Operating Income or Loss
|
11,244,000
|
20,048,000
|
23,549,000
|
19,230,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 11,244,000 | 20,048,000 | 23,549,000 | 19,230,000 |
|
Interest Expense | (2,000,000) | (5,546,000) | (2,804,000) | (1,287,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 2,401,000 | 2,437,000 | 3,991,000 | 4,860,000 |
|
Minority Interest | (31,000) | 21,000 | (129,000) | (11,000) |
|
|
|
Net Income From Continuing Ops | 6,751,000 | 11,964,000 | 16,613,000 | 13,061,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
6,751,000
|
11,964,000
|
16,613,000
|
13,061,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
1.77%